Survival Rate of Childhood Leukemia in Shiraz, Southern Iran

Objective Leukemia is the most prevalent type of cancer in children. The aim of this study was to estimate the 5-year survival rates of Acute Lymphoblastic Leukemia (ALL) and Acute Myeloblastic Leukemia (AML) as well as factors influencing them. Methods This is a nonrandomized retrospective study conducted on 280 patients with ALL and AML. They were all below 15 years old children admitted to Shahid Faghihi hospital, Shiraz, Iran from 2004 to 2008.The survival rates were estimated by applying the Kaplan-Meier method. In addition, the log rank test was used to estimate the statistical significance of differences in the survival probability. Cox regression model was applied to conduct multivariate analysis for adjusting confounding variable. All analyses were performed in SPSS statistical software (version 16). P-values less than 0.05 were considered as statistically significant. Findings The mean (± standard deviation) of the observation period was 28.2±16.1 months. In this period, 60 (24.7%) patients (47 ALL and 15 AML) passed away. The cumulative rate of survival in this study was 53.3±0.1 percent. This probability was 56.6±0.1% and 44.2±0.1% for ALL and AML patients, respectively, which indicates no statistically significant difference between them (P=0.8). According to Cox model, there was a significant relationship among the variables of platelet count and relapse with the survival rate. Conclusion Platelet count was identified as a positive prognostic factor of the survival rate in ALL patients. However, on the base of our results and other studies, incidence of relapse and the number of relapses are significant factors of survival rates of leukemia.

[1]  S. Voss,et al.  Leukemia and lymphoma. , 2011, Radiologic clinics of North America.

[2]  C. Magnani,et al.  Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP). , 2008, European journal of cancer.

[3]  R. Swaminathan,et al.  Childhood cancers in Chennai, India, 1990–2001: Incidence and survival , 2008, International journal of cancer.

[4]  A. Holmes,et al.  Risk Factors for Acute Leukemia in Children: A Review , 2006, Environmental health perspectives.

[5]  E. Steliarova-Foucher,et al.  Geographical comparison of cancer survival in European children (1988-1997): report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.

[6]  E. Steliarova-Foucher,et al.  Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.

[7]  C. Kuehn,et al.  Maternal and birth characteristics in relation to childhood leukaemia. , 2006, Paediatric and perinatal epidemiology.

[8]  D. Hémon,et al.  Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000). , 2006, European journal of cancer.

[9]  N. El-Sharkawy,et al.  Outcome and Prognostic Factors of Acute Lymphoblastic Leukemia in Children at the National Cancer Institute, Egypt , 2004, Journal of pediatric hematology/oncology.

[10]  C. Magnani,et al.  Population-based survival after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979 to 1998--a report from the Childhood Cancer Registry of Piedmont (Italy). , 2003, European journal of cancer.

[11]  H. Yarmohammadi,et al.  An analysis of prognostic factors and the five-year survival rate in childhood acute lymphoblastic leukemia. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[12]  John D Potter,et al.  Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. , 2002, Medical and pediatric oncology.

[13]  J. Buckley,et al.  Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States) , 2002, Cancer Causes & Control.

[14]  J. Coebergh,et al.  Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978--1992: the EUROCARE study. , 2001, European journal of cancer.

[15]  M. Coleman,et al.  Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study. , 2001, European journal of cancer.

[16]  M. Mandelson,et al.  Survival of children with cancer. , 1986, JAMA.

[17]  C. Berger,et al.  Childhood cancer survival in France, 1990-1999. , 2008, European journal of cancer.

[18]  H. Yarmohammadi,et al.  The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran. , 2008, Cancer detection and prevention.

[19]  A. Ohara,et al.  Survival Outcome after the First Central Nervous System Relapse in Children with Acute Lymphoblastic Leukemia: A Retrospective Analysis of 79 Patients in a Joint Program Involving the Experience of Three Japanese Study Groups , 2007, International journal of hematology.

[20]  Ching-Hon Pui,et al.  Childhood and adolescent lymphoid and myeloid leukemia. , 2004, Hematology. American Society of Hematology. Education Program.